farmasino enasidenib api

Enasidenib Mesylate (1650550-25-6) Enasidenib is a first-in-class oral selective inhibitor of mutant IDH2 enzymes (isocitrate dehydrogenase 2), indicated for the treatment of adults with relapsed or refractory IDH2-mutated acute myeloid leukemia. Product Name: Enasidenib mesylate CAS No.: 1650550-25-6 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C20 H21 F6 N7 O4 S Molecular Weight: 569.48 Shelf Life: 2 Years Package: 25kg/drum